Home

asdasd22d
Title: Slide 1
Title Credit Type Therapeutic Area Format
Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies AANP, CME, CNE, CPE Oncology On-Demand Webcast
CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy AANP, CME, CNE, CPE Oncology On-Demand Webcast
Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy AANP, CME, CNE, CPE Oncology On-Demand Webcast
Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies AANP, CME, CNE, CPE Oncology On-Demand Webcast
Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations AANP, CME, CNE, CPE Oncology On-Demand Webcast
PI3K Inhibitors in the Treatment of Non-Hodgkin Lymphomas AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
COVID-19 Update: Adapting Management Strategies and Vaccine Recommendations AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
PI3K and EZH2 Inhibitors in the Treatment of Non-Hodgkin Lymphomas AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Novel Therapeutic Targets in Advanced Classic Hodgkin Lymphoma: Present and Future Challenges AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Advances in the Treatment of ALL in Adults: Treatment Approaches for Ph Positivity AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Advances in R/R Multiple Myeloma: Overcoming Treatment Resistance with Novel Targets AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Adverse Effects of Targeted Agents: Identification and Management Strategies for Patients with B-Cell Malignancies AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast

Pages